Sector: MedicalSantarus, Inc. (NASDAQ: SNTS)
Ranking History
Scan Date: | 11/17/2009 |
Sector: | Medical |
Funamental : | 32 |
Technical : | 27 |
Performance : | 80 |
Overall: | 8 |
Number of Stocks: | 307 |
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 24 |
Technical : | 120 |
Performance : | 125 |
Overall: | 46 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 286 |
Technical : | 252 |
Performance : | 229 |
Overall: | 291 |
Number of Stocks: | 306 |
Headlines
- Santarus to Present at Piper Jaffray 21st Annual Health Care Conference
Nov 24, 2009 04:00 AM | PJC, SNTS
- Santarus to Present at Lazard Capital Markets 6th Annual Healthcare Conference
Nov 10, 2009 04:00 AM | SNTS
- Santarus Reports Third Quarter 2009 Financial Results
Nov 04, 2009 04:05 PM | SNTS
- Positive Data from Two Investigator-Initiated Studies with Santarus' ZEGERID to Be Presented At ACG
Oct 26, 2009 04:00 AM | SNTS
- Santarus to Hold Third Quarter 2009 Financial Results Conference Call on November 4
Oct 23, 2009 04:00 AM | SNTS
- Santarus Ranked Number 23 Fastest Growing Company in North America on Deloitte's 2009 Technology Fast 500(TM)
Oct 20, 2009 08:15 AM | SNTS
- Santarus and Norgine Enter License for ZEGERID Immediate-Release Omeprazole Products in Europe
Oct 12, 2009 04:00 AM | SNTS
- StockPreacher.com Issues Trading Outlook for DepoMed Inc.
Oct 07, 2009 06:53 AM | BVF, DEPO, MNKD, NVO, SNTS
- Depomed to Present at BioCentury's NewsMakers in the Biotech Industry Conference
Sep 09, 2009 08:30 AM | DEPO, SNTS
- Depomed to Present at Rodman & Renshaw Annual Global Investment Conference
Sep 02, 2009 08:30 AM | DEPO, SNTS
- Depomed Promotes William Callahan to Vice President of Operations
Nov 18, 2009 09:55 AM | DEPO, JNJ, SNTS
- Depomed Receives Notice of Paragraph IV Certification Against Patents for GLUMETZA®
Nov 10, 2009 09:51 AM | DEPO, SNTS
- Santarus Reports Second Quarter 2009 Financial Results
Aug 03, 2009 04:51 PM | DEPO, SNTS
- Santarus to Present at BMO Capital Markets Focus on Healthcare Conference
Jul 29, 2009 04:02 AM | SNTS
- Santarus to Hold Second Quarter 2009 Financial Results Conference Call on August 3
Jul 23, 2009 04:01 AM | SNTS
- Depomed Provides License for Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.
Jul 22, 2009 05:57 AM | DEPO, MRK, SNTS
- Schering-Plough Reports Financial Results for 2009 Second Quarter ; Diversification Strategy and Strong Execution Continue to Drive Solid Performance;; Robust Pipeline Continues To Advance and Build Long-Term Value
Jul 21, 2009 02:52 PM | JNJ, MRK, SGP, SNTS
- Schering-Plough Reports Financial Results for 2009 Second Quarter
Jul 21, 2009 06:52 AM | JNJ, MRK, SGP, SNTS
- Santarus Joins the Russell 3000 Index
Jun 26, 2009 04:01 AM | SNTS
- Santarus Announces December 2009 Action Date for Schering-Plough’s OTC ZEGERID New Drug Application
Jun 23, 2009 04:02 AM | SNTS
- Form 4 SANTARUS INC For: Nov 16 Filed by: DENBY WILLIAM C (10K)
Nov 17, 2009 05:04 PM
- Form 4 SANTARUS INC For: Nov 16 Filed by: HALL WARREN E (10K)
Nov 17, 2009 05:01 PM
- Form 4 SANTARUS INC For: Nov 11 Filed by: HALL WARREN E (10K)
Nov 12, 2009 05:23 PM
- Form 4 SANTARUS INC For: Nov 11 Filed by: DENBY WILLIAM C (10K)
Nov 12, 2009 05:20 PM
- Form 4 PROEHL GERALD T For: Nov 03 (10K)
Nov 04, 2009 06:55 PM
- Form 4 Step Michael D For: Aug 03 (10K)
Aug 04, 2009 07:18 PM
- Form 4 PROEHL GERALD T For: Aug 03 (10K)
Aug 04, 2009 07:15 PM
- Form 4 HALL WARREN E For: Aug 03 (10K)
Aug 04, 2009 07:07 PM
- Form 4 Fox Carey J For: Aug 03 (10K)
Aug 04, 2009 07:03 PM
- Form 4 DENBY WILLIAM C For: Aug 03 (10K)
Aug 04, 2009 06:58 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
SNTS
|
Compare to S&P
|
| YTD |
154.78 %
|
110.86 %
|
| 4 Weeks |
22.70 %
|
21.38 %
|
| 12 Weeks |
25.00 %
|
17.85 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 350.00 %
|
|
EPS Growth in Last Year: 212.50 %
|
|
Sales Growth in Last Quarter: 10.06 %
|
|
Sales Growth in Last Quarter: 22.49 %
|
|
